GLS and fatty liver disease: In contrast, the overexpression of GLS1 in the liver resulted in significantly decreased hepatic steatosis, as evidenced by decreased hepatic TG contents (Figure 4I), improved liver histology observed via H&E staining (Figure 4J), and decreased lipogenic gene and protein levels (Figure 4K; Figure S8G, Supporting Information).